EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polynuclear Silver(I)–Quinoxaline Complex: Comprehensive Structural Characterization, Antimycobacterial Properties and DNA/BSA Binding Study

Ghada Bouz iD, Nevena L Stevanović iD, Marta Počkaj iD, Tina P Andrejević iD, Iztok Turel iD, Ondřej Jand'ourek iD, Klára Konečná iD, Žiko Milanović, Kristina Milisavljević, Biljana Đ Glišić iD

Pharmaceutics · 27.01.2026 · 18 (2) · 169

DOI: 10.3390/pharmaceutics18020169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 27.01.2026. Verfasst von Ghada Bouz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 03 Hradec Králové, Czech Republic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation of the Republic of Serbia, The Slovenian Research and Innovation Agency, European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Silver(I) complexes with aromatic heterocyclic ligands are well known for their broad antimicrobial potential, largely attributed to their ability to interact with biomolecular targets. Results and Discussion: In this study, a new polynuclear silver(I) complex with N-(3′-phenylpropyl)quinoxaline-2-carboxamide (pqx-2ca), [Ag(NO3)(pqx-2ca)]n, was synthesized. Its structure was confirmed by single-crystal X-ray diffraction and comprehensively characterized using NMR, IR, and UV–Vis spectroscopy, while its behavior in solution was further elucidated through density functional theory (DFT) calculations combined with spectral simulations. The complex demonstrated significantly enhanced antimycobacterial activity compared with the free ligand when tested against the avirulent Mycobacterium tuberculosis H37Ra, fast-growing model organisms M. smegmatis and M. aurum, as well as the nontuberculous species M. avium and M. kansasii. Experimental and docking studies confirmed stable binding of the complex to subdomain III of bovine serum albumin (BSA) and to the minor groove of DNA. Furthermore, docking to validated mycobacterial targets revealed inhibitory potential toward the InhA and MmpL3 proteins, with binding affinities comparable to those of standard inhibitors.

Conclusions

These results highlight [Ag(NO3)(pqx-2ca)]n as a promising candidate for the development of silver-based antimycobacterial agents with a dual mechanism of action involving both DNA and protein targets.

Schlagwörter

Stichwörter der Autor:innen

DNA interactionN-substituted quinoxaline-2-carboxamidesantimycobacterial activityprotein interactionsilver(I) complexes

Autor:innen und Institutionen

  • Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 03 Hradec Králové, Czech Republic.
  • Faculty of Pharmacy, University of Business Academy in Novi Sad, Heroja Pinkija 4, 21000 Novi Sad, Serbia.
  • Department of Chemistry, Faculty of Science, University of Kragujevac, R. Domanovića 12, 34000 Kragujevac, Serbia.
  • Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia.
  • Department of Science, Institute for Information Technologies Kragujevac, University of Kragujevac, Liceja Knezevine Srbije 1A, 34000 Kragujevac, Serbia.

ORCID-Profile: Ghada Bouz, Nevena L Stevanović, Marta Počkaj, Tina P Andrejević, Iztok Turel, Ondřej Jand'ourek, Klára Konečná, Biljana Đ Glišić

Förderung

  • Ministry of Science, Technological Development and Innovation of the Republic of Serbia
  • The Slovenian Research and Innovation Agency
  • European Cooperation in Science and Technology

Zitieren

APA

Bouz, G., Stevanović, N. L., Počkaj, M., Andrejević, T. P., Turel, I., Jand'ourek, O., Konečná, K., Milanović, Ž., Milisavljević, K., & Glišić, B. Đ. (2026). Polynuclear Silver(I)–Quinoxaline Complex: Comprehensive Structural Characterization, Antimycobacterial Properties and DNA/BSA Binding Study. Pharmaceutics, 18(2), 169. https://doi.org/10.3390/pharmaceutics18020169

Vancouver

Bouz G, Stevanović NL, Počkaj M, Andrejević TP, Turel I, Jand'ourek O, et al. Polynuclear Silver(I)–Quinoxaline Complex: Comprehensive Structural Characterization, Antimycobacterial Properties and DNA/BSA Binding Study. Pharmaceutics. 2026;18(2):169. doi:10.3390/pharmaceutics18020169

BibTeX
@article{Bouz2026,
  author = {Bouz, Ghada and Stevanović, Nevena L and Počkaj, Marta and Andrejević, Tina P and Turel, Iztok and Jand'ourek, Ondřej and Konečná, Klára and Milanović, Žiko and Milisavljević, Kristina and Glišić, Biljana Đ},
  title = {Polynuclear Silver(I)–Quinoxaline Complex: Comprehensive Structural Characterization, Antimycobacterial Properties and DNA/BSA Binding Study},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {169},
  doi = {10.3390/pharmaceutics18020169}
}
Kostenlos starten →